Suppr超能文献

腹部开放处理中抗生素停用后暴发性细菌性腹膜炎复发的预测因素

Predictors of recurrence of fulminant bacterial peritonitis after discontinuation of antibiotics in open management of the abdomen.

作者信息

Visser M R, Bosscha K, Olsman J, Vos A, Hulstaert P F, van Vroonhoven T J, van der Werken C

机构信息

Department of Clinical Microbiology, University Hospital Utrecht, The Netherlands.

出版信息

Eur J Surg. 1998 Nov;164(11):825-9. doi: 10.1080/110241598750005228.

Abstract

OBJECTIVE

To assess a scoring system for predicting recurrence of fulminant bacterial peritonitis after discontinuation of antimicrobial treatment in patients being treated by open management of the abdomen for persistent bacterial peritonitis after perforation of the digestive tract, anastomotic disruption, or necrotising pancreatitis.

DESIGN

Retrospective study.

SETTING

University Hospital, The Netherlands.

SUBJECTS

58 consecutive patients.

MAIN OUTCOME MEASUREMENTS

Recurrence of fulminant bacterial peritonitis and survival.

RESULTS

13 of the 58 patients (22%) died during the initial course of antimicrobial drugs. 14 of the remaining 45 patients had a recurrence of fulminant bacterial peritonitis after discontinuation of antimicrobial drugs, 4 of whom died. Predictive criteria included raised white cell count (WCC) (p = 0.02), duration of initial antibiotic treatment (p = 0.05), and deterioration in Simplified Acute Physiology Score (p = 0.05). Using the WCC and the duration of initial antimicrobial treatment together with other variables that showed a predictive trend (body temperature, percentage band cells, underlying disease, and use of inotropic agents), in a new scoring system (0-12), fulminant bacterial peritonitis did not recur when the score was 0-3, but in 9 of 11 patients with a score of 6 or more it did (p < 0.001).

CONCLUSION

Patients at increased risk of recurrence of fulminant bacterial peritonitis during open management of the abdomen can be identified at the time of discontinuation of antimicrobial treatment by a new scoring system; antimicrobial treatment should not be discontinued in patients with a score of 6 or more.

摘要

目的

评估一种评分系统,用于预测在因消化道穿孔、吻合口破裂或坏死性胰腺炎导致持续性细菌性腹膜炎而接受腹部开放治疗的患者中,抗菌治疗停止后暴发性细菌性腹膜炎的复发情况。

设计

回顾性研究。

地点

荷兰大学医院。

研究对象

58例连续患者。

主要观察指标

暴发性细菌性腹膜炎的复发和生存情况。

结果

58例患者中有13例(22%)在初始抗菌药物治疗过程中死亡。其余45例患者中有14例在抗菌药物停用后出现暴发性细菌性腹膜炎复发,其中4例死亡。预测标准包括白细胞计数(WCC)升高(p = 0.02)、初始抗生素治疗持续时间(p = 0.05)以及简化急性生理学评分恶化(p = 0.05)。在一个新的评分系统(0 - 12分)中,将WCC、初始抗菌治疗持续时间与其他显示出预测趋势的变量(体温、杆状核细胞百分比、基础疾病和使用的血管活性药物)结合起来,当评分在0 - 3分时,暴发性细菌性腹膜炎未复发,但在11例评分6分及以上的患者中有9例复发(p < 0.001)。

结论

通过一种新的评分系统,在腹部开放治疗期间暴发性细菌性腹膜炎复发风险增加的患者,在抗菌治疗停止时可以被识别出来;评分6分及以上的患者不应停止抗菌治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验